BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36095092)

  • 21. Relationship between type of smokeless tobacco & risk of cancer: A systematic review.
    Gupta S; Gupta R; Sinha DN; Mehrotra R
    Indian J Med Res; 2018 Jul; 148(1):56-76. PubMed ID: 30264755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinogenicity of smokeless tobacco: Evidence from studies in humans & experimental animals.
    Warnakulasuriya S; Straif K
    Indian J Med Res; 2018 Dec; 148(6):681-686. PubMed ID: 30778001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
    Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
    Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers.
    Hoffmann D; Adams JD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4305-8. PubMed ID: 7198005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users.
    Nair J; Ohshima H; Nair UJ; Bartsch H
    Crit Rev Toxicol; 1996; 26(2):149-61. PubMed ID: 8688158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium.
    Wyss AB; Hashibe M; Lee YA; Chuang SC; Muscat J; Chen C; Schwartz SM; Smith E; Zhang ZF; Morgenstern H; Wei Q; Li G; Kelsey KT; McClean M; Winn DM; Schantz S; Yu GP; Gillison ML; Zevallos JP; Boffetta P; Olshan AF
    Am J Epidemiol; 2016 Nov; 184(10):703-716. PubMed ID: 27744388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
    Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
    Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
    Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A qualitative and quantitative risk assessment of snuff dipping.
    Nilsson R
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):1-16. PubMed ID: 9784428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Smokeless Tobacco with Oral Cancer - Evidence From the South Asian Studies: A Systematic Review.
    Awan KH; Patil S
    J Coll Physicians Surg Pak; 2016 Sep; 26(9):775-80. PubMed ID: 27671184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
    Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
    Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.
    Stepanov I; Biener L; Knezevich A; Nyman AL; Bliss R; Jensen J; Hecht SS; Hatsukami DK
    Nicotine Tob Res; 2012 Mar; 14(3):274-81. PubMed ID: 22039075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The health impact of smokeless tobacco products: a systematic review.
    Hajat C; Stein E; Ramstrom L; Shantikumar S; Polosa R
    Harm Reduct J; 2021 Dec; 18(1):123. PubMed ID: 34863207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxic and carcinogenic agents in dry and moist snuff.
    Hoffmann D; Adams JD; Lisk D; Fisenne I; Brunnemann KD
    J Natl Cancer Inst; 1987 Dec; 79(6):1281-6. PubMed ID: 3480379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naswar (Smokeless Tobacco) Use and the Risk of Oral Cancer in Pakistan: A Systematic Review With Meta-Analysis.
    Khan Z; Suliankatchi RA; Heise TL; Dreger S
    Nicotine Tob Res; 2019 Jan; 21(1):32-40. PubMed ID: 29294113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Coronary Heart Disease Among Smokeless Tobacco Users: Results of Systematic Review and Meta-Analysis of Global Data.
    Gupta R; Gupta S; Sharma S; Sinha DN; Mehrotra R
    Nicotine Tob Res; 2019 Jan; 21(1):25-31. PubMed ID: 29325111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New brands of oral snuff.
    Hoffmann D; Djordjevic MV; Brunnemann KD
    Food Chem Toxicol; 1991 Jan; 29(1):65-8. PubMed ID: 1999307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of smokeless tobacco-associated bacteriome in oral carcinogenesis.
    Sajid M; Srivastava S; Joshi L; Bharadwaj M
    Anaerobe; 2021 Aug; 70():102400. PubMed ID: 34090995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of oral bacteriome of smokeless tobacco users and their association with oral cancer.
    Sajid M; Sharma P; Srivastava S; Hariprasad R; Singh H; Bharadwaj M
    Appl Microbiol Biotechnol; 2023 Jun; 107(12):4009-4024. PubMed ID: 37154908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smokeless tobacco use and risk of cancer of the pancreas and other organs.
    Boffetta P; Aagnes B; Weiderpass E; Andersen A
    Int J Cancer; 2005 May; 114(6):992-5. PubMed ID: 15645430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.